Superworth

Quoin Pharmaceuticals shares outstanding QNRX

Diluted shares outstanding, averaged over each quarter, from 2022.

Latest quarter, to Jun 30, 2026
2.8M
On a year earlier
+381.7%
more shares

Quoin Pharmaceuticals had 2.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.

That is 381.7% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY20252.5M+1303%
FY2024177.7K−82%
FY2023987.2Kn/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q2 FY262.8M+382%
Q1 FY262.8M+383%
Q4 FY252.5M+1303%
Q3 FY25588.2K+308%
Q2 FY25588.2K+308%
Q1 FY25586.3K+876%
Q4 FY24177.7K−82%
Q3 FY24144.3K−85%
Q2 FY24144.3K−85%
Q1 FY2460.1K−91%
Q4 FY23987.2Kn/a
Q3 FY23987.2K+260%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Quoin Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.